Job Duties: Provides timely and scientific sound expertise in the biomarker analysis in clinical biospecimens in clinical studies using our bispecific therapeutics (T cell engagers, checkpoint inhibitors, targeted and engineered cytokines, and other modalities).  Leads the development of biomarker plans and clinical biomarker data analysis, interpretation, and presentation to internal and external stakeholders Provides ancillary support for clinical biomarkers including program management assistance and expert internal bioinformatics, including a web-based portal dashboard to analyze all clinical endpoints and biomarkers

Job Duties: Integrates pharmacokinetic and pharmacology expertise to support preclinical and clinical activities for programs including T-cell engaging bispecifics, dual checkpoint inhibitors and anti-cytokines Supports pre-IND activities including FIH dose selection Collaborates cross-functionally with Research/Biometric/Bioinformatics/Clinical/ Translational team to analyze and integrate PKPD and activity readouts to inform dose optimization, dose-escalation/expansion and RP2D decisions Leads the execution of clinical pharmacology studies Authors and reviews documents including clinical protocols, and regulatory submissions such as briefing documents

Chief Business Officer Location: San Francisco, CA Company Overview: Our client is a cutting-edge biotech startup revolutionizing the field of genetic medicine with proprietary Lipid Nanoparticle (LNP) technology. Their patented delivery mechanism offers superior efficacy and safety compared to traditional RNA or DNA delivery methods. Founded by a visionary PhD graduate from Stanford University, the company is driven by a passion for innovation and a commitment to transforming healthcare through advanced biotechnology. Position Overview: We are seeking a dynamic